Significant upside for pharma stock prices, dividends

Pharmaceutical firms' adept handling of patent expirations has boosted investors' opinions of the sector, says Morningstar's Damien Conover.

Jeremy Glaser 8 February, 2012 | 3:00AM
Facebook Twitter LinkedIn



Jeremy Glaser: For Morningstar, I am Jeremy Glaser. To give us an update on the Big Pharma space, I am here today with Damien Conover; he is our associate director of health care.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free
Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar Rating
Abbott Laboratories118.22 USD1.20Rating
AstraZeneca PLC ADR59.95 USD1.11Rating
Bayer AG ADR13.74 USD0.83Rating
Eli Lilly and Co240.53 USD0.65Rating
GlaxoSmithKline PLC ADR39.07 USD1.07Rating
Johnson & Johnson163.76 USD2.27Rating
Merck & Co Inc78.68 USD1.98Rating
Pfizer Inc41.99 USD1.62Rating
Roche Holding AG ADR48.60 USD-1.14Rating
Sanofi SA ADR47.71 USD-0.67Rating

About Author

Jeremy Glaser

Jeremy Glaser  Jeremy Glaser is the Markets Editor for

© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy